Rare Disease Biotech Offers Access Ahead of Key Milestone
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Shares Stats
Shares Outstanding | 2,503,140,000 |
Shares Float | 2,495,380,000 |
Shares Short | 27,710,000 |
Insider Holdings | 7% |
Institution Holdings | 80.62% |
About Merck & Co Inc
Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and anti-PD-1 therapy, as well as KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
General
Name | Merck & Co Inc |
Ticker | MRK |
Exchange | NYSE |
Sector | Healthcare |
Industry | Drug Manufacturers - General |
Currency | USD |
Country | USA |
Fiscal Year End | December |
Full Time Employees | 73,000 |
Highlights
Analyst Target | 101.95 |
Market Cap | 223,476,700,000 |
PE Ratio | 13.79 |
PEG Ratio | 0.81 |
EBITDA | 28,330,000,384 |
Financials
Curr Year EPS Estimate | 8.93 |
Next Quarter EPS Estimate | 2.42 |
Profit Margin | 25.87% |
Operating Margin | 35.05 |
Return on Assets | 0.13 |
Return on Equity | 0.35 |
Revenue | 63.4B |
Earnings Per Share | 6.49 |
Revenue Per Share | 25.21 |
Gross Profit | 49,245,999,104 |
Quarterly Revenue Growth | -0.02 |
Valuation
Trailing PE | 13.79 |
Forward PE | 9.20 |
Price/Sales (Trailing 12 Mt.) | 3.51 |
Price/Book (Most Recent Quarter) | 4.60 |
Dividend
Merck & Co Inc pays out a dividend of $3.22 per share, with a dividend yield of 3.60%.
MRK's next dividend payment will be made to shareholders on October 7, 2025.
They pay out 46.32% of their earnings out as a dividend.
Recent Dividends
Oct 7, 2025 | $0.81 |
Jul 8, 2025 | $0.81 |
Apr 7, 2025 | $0.81 |
Jan 8, 2025 | $0.81 |
Oct 7, 2024 | $0.77 |
Jul 8, 2024 | $0.77 |
Apr 5, 2024 | $0.77 |
Jan 8, 2024 | $0.77 |
FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite
FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are working on legislation to ban lawmakers and cabinet members from buying and selling stocks.
Nvidia to invest $5 billion in Intel; companies will work together on AI infrastructure and PCs
NEW YORK (AP) — Nvidia, the world's leading chipmaker, announced on Thursday that it's investing $5 billion in Intel and it will collaborate with the struggling semiconductor company on products.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Here's How Much You Would Have Made Owning United Rentals Stock In The Last 20 Years
United Rentals (NYSE: URI) has outperformed the market over the past 20 years by 12.61% on an annualized basis producing an average annual return of 21.43%. Currently, United Rentals has a market capitalization of $59.92 billion.
Cathie Wood's Reshuffle Tuesday: Loads Up On AMD, Figma And Bullish, Trims Tempus AI
On Tuesday, Cathie Wood-led Ark Invest executed significant trades, including buying shares of Advanced Micro Devices Inc. (NASDAQ:AMD) and Bullish Inc. (NYSE:BLSH), while selling shares o
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Ukraine expects $3.5 billion fund for US weapons to sustain fight against Russia, Zelenskyy says
KYIV, Ukraine (AP) — Ukraine expects there will be around $3.5 billion by next month in a fund to buy weapons from the United States and help sustain its against Russia’s all-out invasion, Ukrainian President Volodymyr Zelenskyy said Wednesday.
Spirit Airlines to furlough 1,800 flight attendants amid second bankruptcy
Spirit Airlines plans to furlough 1,800 flight attendants before the end of the year, the cash-strapped budget carrier said Monday.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
What You Need to Know About Annuities
Retirement researchers are often enthusiastic about annuities, but many consumers are reasonably skeptical. Here to discuss basic information about annuities and their pros and cons is Christine Benz, Morningstar’s director of personal finance and retirement planning.
Trump Makes Chinese Stocks Great Again — Until Someone Mentions Tariffs
President Donald Trump's recent optimistic remarks on negotiations with China have given a boost to U.S.-listed Chinese stocks.
[Revealed] Trump's Next AI Executive Orders? - Ad
A White House insider with direct ties to Trump's inner circle just revealed what he calls "Manhattan II" - a potential $2.2 trillion AI initiative set to launch as soon as Oct 15. He says this could mirror past U.S. projects that minted fortunes - with small firms soaring 5,000% to 10,000% over two decades. And now he's giving away his #1 stock pick for free before the deadline.
Ben & Jerry's Co-Founder Resigns In Protest As Politics Continue To Influence Corporate Exits
Jerry Greenfield, of Ben & Jerry's fame, didn't resign over personal controversy—he quit because his company stopped being political enough.
Gov. Stein requests $13.5B more from Congress for Hurricane Helene recovery
FLAT ROCK, N.C. (AP) — North Carolina Gov. Josh Stein on Monday requested $13.5 billion more from Congress in recovery aid for almost a year after the historic storm, saying additional help is needed from Washington to address record amounts of damage and to get funds to the region quicker.
Nvidia Is About to Shock the World: October 23rd - Ad
Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: October 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.
Asian shares trade mixed after Wall Street sets new records
TOKYO (AP) — Asian shares traded mixed on Tuesday after Wall Street set new records as investor anticipation grew that the U.S. Federal Reserve will announce the first cut of the year on its main interest rate.
Pilgrims turn Spain's Santiago de Compostela into the world's latest overtourism flashpoint
SANTIAGO DE COMPOSTELA, Spain (AP) — While some Barcelona residents sought to repel a tsunami of tourists , a neighborhood association in Santiago de Compostela opted for a friendlier approach: a guide to good manners for visitors to their town, the endpoint of the Catholic world's most famous pilgrimage.
The "Mar-A-Lago Accord" Is Now Underway - Ad
The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)
Ethereum Faces Alt-Season Pressure: Why Fusaka Upgrade Could Be A Gamechanger
Ethereum is once again under the spotlight as traders declare the arrival of a fresh alt-season. With capital rotating into high-beta tokens like Solana, Avalanche, and meme coins, Ethereum (Crypto: ETH) finds itself squeezed between being the "blue-chip" altcoin and the slowest horse in a fast-moving race.
UNHCR official warns that the 1951 refugee convention is increasingly under threat
The U.N. refugee agency said Wednesday that governments around the world, especially in the Global North, and , are increasingly undermining the global convention on refugees and asylum-seekers — even threatening its very existence.
Gold Is Being Reintroduced Into the Monetary System - Ad
While the media focuses on political scandals, inflation and coming up with ridiculous acronyms "TACO"... Smart money is tracking a far bigger shift: a gold revaluation is quietly underway. Garrett Goggin, CFA, says this could trigger 100X moves in select miners - and he's identified four with the biggest upside.
Judge Tosses Trump's $15 Billion Case Against New York Times, President Claims He's 'Winning'
A federal judge dismissed Trump's $15 billion defamation lawsuit against The New York Times, calling it "decidedly improper," but gave him 28 days to resubmit it with a 40-page limit.
Federal government sues Uber over alleged discrimination against people with disabilities
The federal government said Friday that it is suing Uber for against passengers with disabilities.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.
Zelenskyy calls for a European air defense system as Russian strike wounds 20 in Ukrainian city
KYIV, Ukraine (AP) — Russian forces bombarded the southern Ukrainian city of Zaporizhzhia with rockets overnight, wounding 20 people, including four children, President Volodymyr Zelenskyy said Tuesday as he urged European leaders to make the continent safe by building an ambitious air defense umbrella.
Nio, Rivian, Moderna, Meta And Bitmine Immersion: Why These 5 Stocks Are On Investors' Radars Today
On Tuesday, U.S. markets slipped, with the Dow Jones Industrial Average falling about 0.3% to 45,757.90, the S&P 500 retreating 0.1% to 6,606.76, and the Nasdaq edging down 0.07% to 22,333.96.These are the top stocks that gained the attention of retail traders and investors throughout the day.
Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad
A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.
Why Rivian Automotive Stock Is Gaining Today?
Rivian stock climbs after breaking ground on a multibillion-dollar Georgia EV plant.
British department store Harrods warns customers that some personal details taken in data breach
LONDON (AP) — Harrods, the luxury British department store, has warned some customers that their personal data may have been taken in a breach of its online systems.
Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad
This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.
Trump Links Sanctions On Russia To NATO Unity, Calls Out Hungary And Slovakia Over Oil Purchases
Trump stated that sanctions on Russia would only be imposed if all NATO countries agree to identical measures and halt Russian oil purchases.
Appeals court rejects Trump's bid to unseat Federal Reserve governor Lisa Cook ahead of rate vote
WASHINGTON (AP) — An appeals court ruled Monday that can remain a Federal Reserve governor, rebuffing President Donald Trump’s efforts to remove her just ahead of a key vote on interest rates.
New Biotech Offering Targets $426B Rare Disease Market - Ad
The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.
Nucor And Reliance Seen As Steel's Strongest Defenders Against Market Challenges
NA steel sector struggles with pricing & demand, leaving investors cautious. HRC prices down 6%, but mills gaining market share & utilization up.
Republican leaders reject Democratic health care demands for bill to avoid shutdown
WASHINGTON (AP) — Republican leaders in the House and Senate said Wednesday that they will reject for an immediate , challenging Democrats to vote against a stopgap spending bill that doesn't include them but will keep the government open at the end of the month.
Why This Crypto Skeptic Had a Change of Heart - Ad
He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.
Billionaire says $2.3 billion Banamex stake signals confidence in Mexico's economy
MEXICO CITY (AP) — A day after Citigroup announced it would sell a 25% stake in Banamex to billionaire Fernando Chico Pardo, the Mexican businessman said his $2.3 billion investment should be read as a sign of confidence in Mexico’s government and economic potential.
Secret Service dismantles telecom threat around UN capable of crippling cell service in NYC
NEW YORK (AP) — While close to 150 world leaders prepared to descend on Manhattan for the the U.S. Secret Service was quietly dismantling a massive hidden telecom network across the New York area — a system investigators say could have crippled cell towers, jammed 911 calls and flooded networks with chaos at the very moment the city was most vulnerable.
Elon's $25 Trillion Confession - Ad
Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.
Asian shares retreat after Intel helped drive Wall Street to more records
MANILA, Philippines (AP) — Asian shares mostly retreated Friday after a rally of technology stocks led by Nvidia and Intel
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.